nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—ABCB1—Omeprazole—Barrett's esophagus	0.0686	1	CbGbCtD
Dabigatran etexilate—Oesophageal ulcer—Esomeprazole—Barrett's esophagus	0.0273	0.0392	CcSEcCtD
Dabigatran etexilate—Oesophageal ulcer—Omeprazole—Barrett's esophagus	0.0273	0.0392	CcSEcCtD
Dabigatran etexilate—F2—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.02	0.134	CbGpPWpGaD
Dabigatran etexilate—CES2—Irinotecan Pathway—APC—Barrett's esophagus	0.0159	0.106	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—digestive system—Barrett's esophagus	0.015	0.173	CbGeAlD
Dabigatran etexilate—CES2—E2F transcription factor network—MCL1—Barrett's esophagus	0.0136	0.0909	CbGpPWpGaD
Dabigatran etexilate—CES2—smooth muscle tissue—Barrett's esophagus	0.0116	0.133	CbGeAlD
Dabigatran etexilate—UGT1A9—digestive system—Barrett's esophagus	0.0114	0.131	CbGeAlD
Dabigatran etexilate—Bone disorder—Omeprazole—Barrett's esophagus	0.011	0.0159	CcSEcCtD
Dabigatran etexilate—Gastrooesophageal reflux disease—Omeprazole—Barrett's esophagus	0.011	0.0159	CcSEcCtD
Dabigatran etexilate—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	0.011	0.0159	CcSEcCtD
Dabigatran etexilate—Bone disorder—Esomeprazole—Barrett's esophagus	0.011	0.0159	CcSEcCtD
Dabigatran etexilate—Hyperbilirubinaemia—Esomeprazole—Barrett's esophagus	0.0109	0.0157	CcSEcCtD
Dabigatran etexilate—Hyperbilirubinaemia—Omeprazole—Barrett's esophagus	0.0109	0.0157	CcSEcCtD
Dabigatran etexilate—F2—epithelium—Barrett's esophagus	0.0108	0.124	CbGeAlD
Dabigatran etexilate—Hepatic enzyme increased—Omeprazole—Barrett's esophagus	0.0105	0.0151	CcSEcCtD
Dabigatran etexilate—Hepatic enzyme increased—Esomeprazole—Barrett's esophagus	0.0105	0.0151	CcSEcCtD
Dabigatran etexilate—CES1—Irinotecan Pathway—APC—Barrett's esophagus	0.00938	0.0626	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—digestive system—Barrett's esophagus	0.00915	0.105	CbGeAlD
Dabigatran etexilate—CES2—digestive system—Barrett's esophagus	0.00915	0.105	CbGeAlD
Dabigatran etexilate—Oesophagitis—Esomeprazole—Barrett's esophagus	0.00909	0.0131	CcSEcCtD
Dabigatran etexilate—Oesophagitis—Omeprazole—Barrett's esophagus	0.00909	0.0131	CcSEcCtD
Dabigatran etexilate—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00826	0.0119	CcSEcCtD
Dabigatran etexilate—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00826	0.0119	CcSEcCtD
Dabigatran etexilate—F2—digestive system—Barrett's esophagus	0.00821	0.0945	CbGeAlD
Dabigatran etexilate—CES1—E2F transcription factor network—MCL1—Barrett's esophagus	0.00803	0.0536	CbGpPWpGaD
Dabigatran etexilate—CES1—digestive system—Barrett's esophagus	0.00754	0.0868	CbGeAlD
Dabigatran etexilate—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00722	0.0104	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00722	0.0104	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00722	0.0104	CcSEcCtD
Dabigatran etexilate—Pain in extremity—Omeprazole—Barrett's esophagus	0.00722	0.0104	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00722	0.0104	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00722	0.0104	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00659	0.00949	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00659	0.00949	CcSEcCtD
Dabigatran etexilate—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.0065	0.00936	CcSEcCtD
Dabigatran etexilate—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.0065	0.00936	CcSEcCtD
Dabigatran etexilate—Gastritis—Omeprazole—Barrett's esophagus	0.00639	0.0092	CcSEcCtD
Dabigatran etexilate—Gastritis—Esomeprazole—Barrett's esophagus	0.00639	0.0092	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00637	0.00917	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00637	0.00917	CcSEcCtD
Dabigatran etexilate—Dysphagia—Esomeprazole—Barrett's esophagus	0.00624	0.00898	CcSEcCtD
Dabigatran etexilate—Influenza—Omeprazole—Barrett's esophagus	0.00624	0.00898	CcSEcCtD
Dabigatran etexilate—Influenza—Esomeprazole—Barrett's esophagus	0.00624	0.00898	CcSEcCtD
Dabigatran etexilate—Dysphagia—Omeprazole—Barrett's esophagus	0.00624	0.00898	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Omeprazole—Barrett's esophagus	0.00614	0.00884	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00614	0.00884	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Omeprazole—Barrett's esophagus	0.00608	0.00875	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00608	0.00875	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.0058	0.00835	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.0058	0.00835	CcSEcCtD
Dabigatran etexilate—Infestation—Esomeprazole—Barrett's esophagus	0.00556	0.00801	CcSEcCtD
Dabigatran etexilate—Infestation—Omeprazole—Barrett's esophagus	0.00556	0.00801	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00556	0.00801	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Omeprazole—Barrett's esophagus	0.00556	0.00801	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00541	0.00779	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00541	0.00779	CcSEcCtD
Dabigatran etexilate—Haematuria—Omeprazole—Barrett's esophagus	0.00531	0.00764	CcSEcCtD
Dabigatran etexilate—Haematuria—Esomeprazole—Barrett's esophagus	0.00531	0.00764	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00526	0.00758	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00526	0.00758	CcSEcCtD
Dabigatran etexilate—Epistaxis—Esomeprazole—Barrett's esophagus	0.00525	0.00756	CcSEcCtD
Dabigatran etexilate—Epistaxis—Omeprazole—Barrett's esophagus	0.00525	0.00756	CcSEcCtD
Dabigatran etexilate—Sinusitis—Esomeprazole—Barrett's esophagus	0.00522	0.00752	CcSEcCtD
Dabigatran etexilate—Sinusitis—Omeprazole—Barrett's esophagus	0.00522	0.00752	CcSEcCtD
Dabigatran etexilate—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00504	0.0336	CbGpPWpGaD
Dabigatran etexilate—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00493	0.0071	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00493	0.0071	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00492	0.00708	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00492	0.00708	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00491	0.00707	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00491	0.00707	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Esomeprazole—Barrett's esophagus	0.0049	0.00705	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Omeprazole—Barrett's esophagus	0.0049	0.00705	CcSEcCtD
Dabigatran etexilate—UGT2B15—Biological oxidations—CYP26A1—Barrett's esophagus	0.00466	0.0311	CbGpPWpGaD
Dabigatran etexilate—Immune system disorder—Omeprazole—Barrett's esophagus	0.00451	0.0065	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00451	0.0065	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.0045	0.00648	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.0045	0.00648	CcSEcCtD
Dabigatran etexilate—UGT1A9—Irinotecan Pathway—APC—Barrett's esophagus	0.00438	0.0292	CbGpPWpGaD
Dabigatran etexilate—Malnutrition—Esomeprazole—Barrett's esophagus	0.00435	0.00626	CcSEcCtD
Dabigatran etexilate—Malnutrition—Omeprazole—Barrett's esophagus	0.00435	0.00626	CcSEcCtD
Dabigatran etexilate—Flatulence—Omeprazole—Barrett's esophagus	0.00428	0.00617	CcSEcCtD
Dabigatran etexilate—Flatulence—Esomeprazole—Barrett's esophagus	0.00428	0.00617	CcSEcCtD
Dabigatran etexilate—Back pain—Esomeprazole—Barrett's esophagus	0.00421	0.00606	CcSEcCtD
Dabigatran etexilate—Back pain—Omeprazole—Barrett's esophagus	0.00421	0.00606	CcSEcCtD
Dabigatran etexilate—Anaemia—Esomeprazole—Barrett's esophagus	0.00402	0.00579	CcSEcCtD
Dabigatran etexilate—Anaemia—Omeprazole—Barrett's esophagus	0.00402	0.00579	CcSEcCtD
Dabigatran etexilate—Angioedema—Esomeprazole—Barrett's esophagus	0.00397	0.00572	CcSEcCtD
Dabigatran etexilate—Angioedema—Omeprazole—Barrett's esophagus	0.00397	0.00572	CcSEcCtD
Dabigatran etexilate—Palpitations—Esomeprazole—Barrett's esophagus	0.00384	0.00553	CcSEcCtD
Dabigatran etexilate—Palpitations—Omeprazole—Barrett's esophagus	0.00384	0.00553	CcSEcCtD
Dabigatran etexilate—Cough—Esomeprazole—Barrett's esophagus	0.00379	0.00546	CcSEcCtD
Dabigatran etexilate—Cough—Omeprazole—Barrett's esophagus	0.00379	0.00546	CcSEcCtD
Dabigatran etexilate—Hypertension—Omeprazole—Barrett's esophagus	0.00375	0.0054	CcSEcCtD
Dabigatran etexilate—Hypertension—Esomeprazole—Barrett's esophagus	0.00375	0.0054	CcSEcCtD
Dabigatran etexilate—Chest pain—Esomeprazole—Barrett's esophagus	0.0037	0.00533	CcSEcCtD
Dabigatran etexilate—Arthralgia—Omeprazole—Barrett's esophagus	0.0037	0.00533	CcSEcCtD
Dabigatran etexilate—Chest pain—Omeprazole—Barrett's esophagus	0.0037	0.00533	CcSEcCtD
Dabigatran etexilate—Arthralgia—Esomeprazole—Barrett's esophagus	0.0037	0.00533	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00368	0.00529	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00368	0.00529	CcSEcCtD
Dabigatran etexilate—CES2—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.00362	0.0242	CbGpPWpGaD
Dabigatran etexilate—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00355	0.00511	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00355	0.00511	CcSEcCtD
Dabigatran etexilate—Infection—Esomeprazole—Barrett's esophagus	0.00353	0.00508	CcSEcCtD
Dabigatran etexilate—Infection—Omeprazole—Barrett's esophagus	0.00353	0.00508	CcSEcCtD
Dabigatran etexilate—Shock—Esomeprazole—Barrett's esophagus	0.00349	0.00503	CcSEcCtD
Dabigatran etexilate—Shock—Omeprazole—Barrett's esophagus	0.00349	0.00503	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00348	0.00501	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00348	0.00501	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00347	0.005	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00347	0.005	CcSEcCtD
Dabigatran etexilate—CES2—E2F transcription factor network—CDKN2A—Barrett's esophagus	0.00345	0.023	CbGpPWpGaD
Dabigatran etexilate—Skin disorder—Esomeprazole—Barrett's esophagus	0.00345	0.00496	CcSEcCtD
Dabigatran etexilate—Skin disorder—Omeprazole—Barrett's esophagus	0.00345	0.00496	CcSEcCtD
Dabigatran etexilate—CES2—NRF2 pathway—HGF—Barrett's esophagus	0.00328	0.0219	CbGpPWpGaD
Dabigatran etexilate—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00323	0.00465	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00323	0.00465	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Omeprazole—Barrett's esophagus	0.00316	0.00455	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00316	0.00455	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00312	0.0045	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Omeprazole—Barrett's esophagus	0.00312	0.0045	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00306	0.00441	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00306	0.00441	CcSEcCtD
Dabigatran etexilate—Fatigue—Omeprazole—Barrett's esophagus	0.00306	0.0044	CcSEcCtD
Dabigatran etexilate—Fatigue—Esomeprazole—Barrett's esophagus	0.00306	0.0044	CcSEcCtD
Dabigatran etexilate—Constipation—Esomeprazole—Barrett's esophagus	0.00303	0.00437	CcSEcCtD
Dabigatran etexilate—Constipation—Omeprazole—Barrett's esophagus	0.00303	0.00437	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.0029	0.00418	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.0029	0.00418	CcSEcCtD
Dabigatran etexilate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.0029	0.0193	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.0029	0.0193	CbGpPWpGaD
Dabigatran etexilate—Urticaria—Esomeprazole—Barrett's esophagus	0.00282	0.00406	CcSEcCtD
Dabigatran etexilate—Urticaria—Omeprazole—Barrett's esophagus	0.00282	0.00406	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00281	0.00404	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Omeprazole—Barrett's esophagus	0.00281	0.00404	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00261	0.00376	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00261	0.00376	CcSEcCtD
Dabigatran etexilate—Asthenia—Omeprazole—Barrett's esophagus	0.00255	0.00367	CcSEcCtD
Dabigatran etexilate—Asthenia—Esomeprazole—Barrett's esophagus	0.00255	0.00367	CcSEcCtD
Dabigatran etexilate—Pruritus—Omeprazole—Barrett's esophagus	0.00251	0.00361	CcSEcCtD
Dabigatran etexilate—Pruritus—Esomeprazole—Barrett's esophagus	0.00251	0.00361	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Omeprazole—Barrett's esophagus	0.00243	0.0035	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00243	0.0035	CcSEcCtD
Dabigatran etexilate—Dizziness—Esomeprazole—Barrett's esophagus	0.00235	0.00338	CcSEcCtD
Dabigatran etexilate—Dizziness—Omeprazole—Barrett's esophagus	0.00235	0.00338	CcSEcCtD
Dabigatran etexilate—ABCB1—epithelium—Barrett's esophagus	0.00232	0.0267	CbGeAlD
Dabigatran etexilate—Vomiting—Esomeprazole—Barrett's esophagus	0.00226	0.00325	CcSEcCtD
Dabigatran etexilate—Vomiting—Omeprazole—Barrett's esophagus	0.00226	0.00325	CcSEcCtD
Dabigatran etexilate—Rash—Omeprazole—Barrett's esophagus	0.00224	0.00322	CcSEcCtD
Dabigatran etexilate—Rash—Esomeprazole—Barrett's esophagus	0.00224	0.00322	CcSEcCtD
Dabigatran etexilate—Dermatitis—Esomeprazole—Barrett's esophagus	0.00224	0.00322	CcSEcCtD
Dabigatran etexilate—Dermatitis—Omeprazole—Barrett's esophagus	0.00224	0.00322	CcSEcCtD
Dabigatran etexilate—Headache—Omeprazole—Barrett's esophagus	0.00222	0.0032	CcSEcCtD
Dabigatran etexilate—Headache—Esomeprazole—Barrett's esophagus	0.00222	0.0032	CcSEcCtD
Dabigatran etexilate—CES1—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.00213	0.0142	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—CYP26A1—Barrett's esophagus	0.00212	0.0142	CbGpPWpGaD
Dabigatran etexilate—Nausea—Omeprazole—Barrett's esophagus	0.00211	0.00303	CcSEcCtD
Dabigatran etexilate—Nausea—Esomeprazole—Barrett's esophagus	0.00211	0.00303	CcSEcCtD
Dabigatran etexilate—UGT2B7—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00209	0.014	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—CDKN2A—Barrett's esophagus	0.00203	0.0136	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—GAST—Barrett's esophagus	0.002	0.0134	CbGpPWpGaD
Dabigatran etexilate—CES1—NRF2 pathway—HGF—Barrett's esophagus	0.00194	0.0129	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.00186	0.0124	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.00184	0.0123	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00179	0.012	CbGpPWpGaD
Dabigatran etexilate—ABCB1—digestive system—Barrett's esophagus	0.00177	0.0203	CbGeAlD
Dabigatran etexilate—UGT1A9—Biological oxidations—CYP26A1—Barrett's esophagus	0.00173	0.0115	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.0017	0.0114	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—RELA—Barrett's esophagus	0.00163	0.0109	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.0016	0.0107	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.00136	0.00904	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—RELA—Barrett's esophagus	0.00131	0.00871	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—HGF—Barrett's esophagus	0.00111	0.00742	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGES—Barrett's esophagus	0.00105	0.00702	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.00104	0.00692	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.00101	0.00672	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000953	0.00636	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000909	0.00607	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—HGF—Barrett's esophagus	0.000904	0.00603	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CDX2—Barrett's esophagus	0.000889	0.00593	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000875	0.00584	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000871	0.00581	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000856	0.00571	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—PPARG—Barrett's esophagus	0.000812	0.00542	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CYP26A1—Barrett's esophagus	0.000798	0.00532	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.000795	0.0053	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—TP53—Barrett's esophagus	0.000755	0.00504	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—SST—Barrett's esophagus	0.000692	0.00462	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—SLC9A1—Barrett's esophagus	0.000575	0.00384	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—GAST—Barrett's esophagus	0.000571	0.00381	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.000548	0.00365	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000528	0.00352	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—GAST—Barrett's esophagus	0.000518	0.00346	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGES—Barrett's esophagus	0.000479	0.0032	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—HGF—Barrett's esophagus	0.000441	0.00294	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—SST—Barrett's esophagus	0.000391	0.00261	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGES—Barrett's esophagus	0.000389	0.0026	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.00037	0.00247	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP26A1—Barrett's esophagus	0.000363	0.00242	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—SST—Barrett's esophagus	0.000355	0.00237	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000354	0.00236	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.00034	0.00227	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GAST—Barrett's esophagus	0.000306	0.00204	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP26A1—Barrett's esophagus	0.000295	0.00197	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCL8—Barrett's esophagus	0.00027	0.0018	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PPARG—Barrett's esophagus	0.000262	0.00175	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SLC9A1—Barrett's esophagus	0.000262	0.00175	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000248	0.00166	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000218	0.00146	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SLC9A1—Barrett's esophagus	0.000213	0.00142	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SST—Barrett's esophagus	0.00021	0.0014	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000208	0.00139	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGS2—Barrett's esophagus	0.000206	0.00138	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CXCL8—Barrett's esophagus	0.00019	0.00127	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000188	0.00126	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGES—Barrett's esophagus	0.000179	0.00119	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000172	0.00114	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000152	0.00102	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TP53—Barrett's esophagus	0.000148	0.000987	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000138	0.000923	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	0.000135	0.000903	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARG—Barrett's esophagus	0.00012	0.000797	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000112	0.000748	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APC—Barrett's esophagus	0.000111	0.000741	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	9.76e-05	0.000651	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARG—Barrett's esophagus	9.71e-05	0.000648	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS2—Barrett's esophagus	9.4e-05	0.000627	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RELA—Barrett's esophagus	8.68e-05	0.000579	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL8—Barrett's esophagus	8.18e-05	0.000546	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS2—Barrett's esophagus	7.64e-05	0.00051	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TP53—Barrett's esophagus	5.02e-05	0.000335	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARG—Barrett's esophagus	4.46e-05	0.000297	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS2—Barrett's esophagus	3.51e-05	0.000234	CbGpPWpGaD
